Previous findings have suggested that the distribution of ovarian cancer histopathology subtypes differs in germline BRCA1 and BRCA2 pathogenic variant carriers, compared to non-carriers, with a similar distribution associated with pathogenic variants for the two genes [10]. This evidence concerns the gene BRCA2 and ovarian cancer.